RICHMOND, Calif. (January 11, 2016)—Ekso Bionics Holdings, Inc. a leading global robotic exoskeleton company, announced a new randomized comparative clinical trial is currently underway in Europe. The trial is called, “The MOST Study,” (Mobility improved after stroke when a robotic device was used in comparison to physical therapy) and is being initialized by Professor Dr. med. F. Hamzei, MD, MHBA, Chief physician of Department of Neurological Rehabilitation, Moritz Klinik.

SAN DIEGO, Calif. (January 11, 2016)—ResMed today announced it has entered into a definitive agreement to acquire Inova Labs Inc., a privately held medical device company specializing in the development and commercialization of innovative oxygen therapy products. Oxygen therapy is the largest non-drug delivery medical device segment for the treatment of COPD.

ELKINS PARK, PA (January 7, 2016)—Ground-breaking research led by Alberto Esquenazi, MD, the Director of the Gait & Motion Analysis Laboratory at MossRehab, is the first to study the effects of joystick control position for wheelchair users. Initial data utilizing pressure mapping, dynamic electromyogram, 3D kinematics and patient subjective report, shows central driving has multiple physiological benefits over traditional armrest mounted joysticks.

WASHINGTON, D.C. (January 7, 2016)—On December 29, 2015, CMS published the final rule to Medicare Program: Prior Authorization Process for Certain Durable Medical Equipment, Prosthetics, Orthotics, and Supplies. This comes a year and a half after the proposed rule, which came out on May 28, 2014. Originally CMS proposed that the timeframe for a response to a prior authorization request would be made within 10 days or two days for expedited requests.